Key Segments
By Product
-
Diagnostics
-
Therapeutics
By Cancer Type
-
Breast Cancer
-
Colorectal Cancer
-
Cervical Cancer
-
Prostate Cancer
-
Lung Cancer
-
Others
By End-Use
-
Hospitals & Diagnostic Laboratories
-
Pharmaceutical & Biotechnology Companies
-
Healthcare Data Companies
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
-
Mexico
Europe
-
Eastern Europe
-
Poland
-
Romania
-
Hungary
-
Turkey
-
Rest of Eastern Europe
-
-
Western Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Netherlands
-
Switzerland
-
Austria
-
Rest of Western Europe
-
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Vietnam
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
-
Middle East
-
UAE
-
Egypt
-
Saudi Arabia
-
Qatar
-
Rest of the Middle East
-
-
Africa
-
Nigeria
-
South Africa
-
Rest of Africa
-
Latin America
-
Brazil
-
Argentina
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
-
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Product Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Product Matrix which gives a detailed comparison of the product portfolio of each company
-
Geographic Analysis
-
Additional countries in any of the regions
-
Company Information
-
Detailed analysis and profiling of additional market players (Up to five)
Frequently Asked Questions
Ans: North America dominated in 2024, capturing 43% of market share, supported by advanced healthcare infrastructure, high cancer prevalence, genomic innovation, and strong adoption of precision therapies.
Ans: The Therapeutics segment dominated the Precision Oncology Market during the projected years, holding a commanding 72% revenue share in 2023, driven by targeted drugs and immuno-oncology advances.
Ans: The market’s major growth driver is advancements in genomic research combined with rising demand for personalized medicine, enabling highly targeted, effective, and patient-specific cancer therapies worldwide.
Ans: In 2024, the Precision Oncology Market reached a significant valuation of USD 110.38 billion, underscoring the growing global adoption of personalized, targeted cancer treatment solutions.
Ans: The Precision Oncology Market is projected to grow at a strong compound annual growth rate (CAGR) of 9.35% between 2025 and 2032, reflecting consistent expansion.